Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPRO-NA 275MG TABLET Resolved 2022-06-06 2022-08-22 162077
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-11-03 16938
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-04 2018-08-01 54285
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-18 2019-07-17 69918
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-16 2021-09-27 137581
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-10-14 159719
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-04-27 185927
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-05-28 2021-08-03 140066
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2021-10-22 2021-10-29 147806
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-09-16 2022-10-07 169519
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2022-11-11 2022-12-05 174343
APO-ALENDRONATE/VITAMIN D3 2800UNIT 70MG TABLET Resolved 2023-03-09 2023-04-21 186572
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583

Showing 1641 to 1660 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-CLONAZEPAM .5MG TABLET Discontinued 2018-09-07 2018-09-15 60402
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40947
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2019-01-04 2019-01-04 71189
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672

Showing 41 to 60 of 356